Addition of tiotropium effective in poorly controlled asthma
(HealthDay)—For patients with poorly controlled asthma, the addition of tiotropium to standard therapy is beneficial, according to a study published online Sept. 3 in the New England Journal of Medicine to coi ...
Immunology
Sep 04, 2012 |
not rated yet |
0
German drug firm makes 1st apology for thalidomide (Update)
(AP)—The German manufacturer of a notorious drug that caused thousands of babies to be born with shortened arms and legs, or no limbs at all, issued its first ever apology Friday—50 years after pulling ...
Medications
Aug 31, 2012 |
not rated yet |
1
Added benefit of fampridine is not proven
Fampridine (trade name Fampyra) has been approved in Germany since July 2011 for adult patients suffering from a higher grade walking disability (grades 4 to 7 on the EDSS disability status scale), as a result of multiple ...
Medications
Aug 29, 2012 |
not rated yet |
0
Increased stroke risk at 30-days post-CABG versus PCI
(HealthDay) -- The risk of stroke at 30 days is significantly higher in patients who undergo coronary revascularization with coronary artery bypass graft (CABG) surgery compared to those who undergo percutaneous ...
Cardiology
Aug 21, 2012 |
not rated yet |
0
Canada needs national approach to protect against drug shortages
Canada needs a national approach to managing its supply of pharmaceutical drugs, starting with a mandatory reporting system for drug shortages, argues an editorial in CMAJ (Canadian Medical Association Journal) and CPJ (Cana ...
Medications
Aug 20, 2012 |
not rated yet |
0
Chronic kidney disease increases stroke risk in A-fib
(HealthDay) -- Patients with atrial fibrillation who have chronic kidney disease are at higher risk of stroke or systemic thromboembolism and bleeding, according to a study published in the Aug. 16 issue ...
Diseases, Conditions, Syndromes
Aug 16, 2012 |
not rated yet |
0
Added benefit of eribulin in breast cancer is not proven
Eribulin (trade name: Halaven) was approved in March 2011 for women with locally advanced or metastasizing breast cancer in whom the disease has progressed despite prior drug therapy.
Cancer
Aug 16, 2012 |
not rated yet |
0
Contact lens sensor measures 24-hour intraocular pressure
(HealthDay) -- A contact lens sensor (CLS) provides safe and tolerable 24-hour monitoring of intraocular pressure (IOP) patterns in patients with or suspected of having glaucoma, according to research published ...
Ophthalmology
Aug 15, 2012 |
5 / 5 (1) |
0
KRAS mutations predict shorter survival in lung cancer
(HealthDay) -- For patients with advanced lung adenocarcinomas, KRAS mutations predict shorter survival, according to a study published online July 18 in Cancer.
Cancer
Jul 26, 2012 |
not rated yet |
0
Components ID'd for ideal acne severity global grading tool
(HealthDay) -- Using an established method for consensus building, experts have identified the essential clinical components and features for an acne severity global grading tool, according to research published ...
Diseases, Conditions, Syndromes
Jul 20, 2012 |
not rated yet |
1
Discovery of new heart failure trigger could change the way cardiovascular drugs are made
In their quest to treat cardiovascular disease, researchers and pharmaceutical companies have long been interested in developing new medicines that activate a heart protein called APJ. But researchers at Sanford-Burnham ...
Cardiology
Jul 18, 2012 |
5 / 5 (2) |
0
|
Trials involving switching HIV drugs may not be beneficial to participants
A increasingly used type of HIV study which involves switching patients on one type of antiretroviral therapy (ART) to another, to see whether the new drug is as good as the at preventing replication of the HIV virus, may ...
HIV & AIDS
Jul 17, 2012 |
not rated yet |
0
Real-life spider men using protein found in venom to develop muscular dystrophy treatment
While Spider-Man is capturing the imagination of theatergoers, real-life spider men in Upstate New York are working intently to save a young boy's life.
Medical research
Jul 16, 2012 |
not rated yet |
0
Chemo combo promising for pancreatic neuroendocrine tumors
(HealthDay) -- The combination of temozolomide and bevacizumab seems to benefit patients with advanced pancreatic neuroendocrine tumors (NETs), according to a study published online July 9 in the Journal of ...
Cancer
Jul 13, 2012 |
not rated yet |
0
India firm shakes up cancer drug market with price cuts
Indian pharmaceutical tycoon Yusuf Hamied revolutionised AIDS treatment more than a decade ago by supplying cut-price drugs to the world's poor -- and now he wants to do the same for cancer.
Medications
Jun 17, 2012 |
5 / 5 (6) |
0
